Turkish Version of a Scale Measuring How People View Chronic Pain
Turkish Cross-Cultural Adaptation, Validity, and Reliability of the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale
This study will translate and culturally adapt the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB) into Turkish and evaluate how well and consistently it measures the views of adults with chronic pain. The study will take place at the Physical Medicine and Rehabilitation outpatient clinic of Bilecik Training and Research Hospital. At least 200 adults will be included in the main sample. Participants will complete questionnaires that are expected to take 10 to 15 minutes. An additional 20 people who will not be included in the main sample will take part in a pilot assessment. Fifty participants from the main sample will complete the PEB Scale again after two weeks. No treatment or intervention will be assigned.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Descripción detallada
This is a methodological, cross-sectional study with a prospective test-retest component. The Turkish cross-cultural adaptation will include independent forward translations, reconciliation of the translations, independent back-translations, comparison with the original scale, and review of discrepancies. Seven experts in relevant fields will assess the clarity, cultural suitability, and content relevance of the items. The revised form will be pilot-tested with 20 adults with chronic pain who will not be included in the main sample.
The main psychometric evaluation will include at least 200 adults with chronic pain. Exploratory and confirmatory factor analyses will be used to evaluate the scale structure. Criterion-related validity will be assessed through correlations with pain beliefs, pain-related self-efficacy, pain intensity, interference with daily activities, and pain-related distress. Internal consistency and item characteristics will also be examined. Measurement invariance across selected participant groups will be evaluated using multigroup confirmatory factor analysis.
For test-retest reliability, 50 participants from the main sample whose clinical condition is not expected to change substantially will complete the PEB Scale again after two weeks. Agreement between the two measurements will be assessed using the intraclass correlation coefficient and its 95% confidence interval.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Burcu Bayrak Kahraman, PhD
- Número de teléfono: +905057542411
- Correo electrónico: burcu.bayrak@bilecik.edu.tr
Ubicaciones de estudio
-
-
-
Bilecik, Turquía (Türkiye), 11000
- Bilecik Eğitim ve Araştırma Hastanesi
-
Contacto:
- Burcu Bayrak Kahraman, Assoc. Prof.
- Número de teléfono: +905057542411
- Correo electrónico: burcu.bayrak@bilecik.edu.tr
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Adults aged 18 years or older with physician-diagnosed chronic pain lasting or recurring for more than 3 months who receive follow-up or treatment at the Physical Medicine and Rehabilitation outpatient clinic of Bilecik Training and Research Hospital, Türkiye.
Descripción
Inclusion Criteria:
- Aged 18 years or older.
- Voluntarily agrees to participate in the study.
- Has physician-diagnosed chronic pain lasting or recurring for more than 3 months.
- Able to read and write Turkish.
- Has sufficient cognitive ability to understand and complete the data collection forms.
Exclusion Criteria:
- Presents with acute pain or does not meet the chronic pain criteria.
- Has a cognitive or communication impairment that prevents completion of the data collection forms.
- Submits incomplete data collection forms.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: OTHER
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
|---|
|
Adults With Chronic Pain
Adults aged 18 years or older with physician-diagnosed chronic pain lasting or recurring for more than 3 months. At least 200 participants will be included in the main sample, and an additional 20 participants will take part in the pilot assessment. Fifty participants from the main sample will complete the PEB Scale again after two weeks. No intervention will be assigned. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Construct validity and internal consistency of the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale
Periodo de tiempo: At the initial assessment (single administration)
|
The Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB Scale) consists of 11 items rated on a 4-point scale (1-4), yielding a total score of 11-44. Higher scores indicate stronger endorsement of the biopsychosocial model of chronic pain and represent a more favorable outcome. Construct validity will be evaluated using exploratory and confirmatory factor analyses. Internal consistency will be assessed using Cronbach's alpha and corrected item-total correlations. |
At the initial assessment (single administration)
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Test-retest reliability of the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale
Periodo de tiempo: At the initial assessment and 2 weeks later
|
The Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB Scale) consists of 11 items rated on a 4-point scale (1-4), yielding a total score of 11-44. Higher scores indicate stronger endorsement of the biopsychosocial model of chronic pain and represent a more favorable outcome. A subsample of 50 participants will complete the scale again after 2 weeks. Test-retest reliability will be evaluated using the intraclass correlation coefficient (ICC) and its 95% confidence interval. |
At the initial assessment and 2 weeks later
|
|
Criterion-related validity of the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale
Periodo de tiempo: At the initial assessment
|
Criterion-related validity will be assessed by examining correlations between scores on the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB Scale), the Pain Beliefs Questionnaire, the University of Washington Pain-Related Self-Efficacy Scale Short Form, and three 0-10 Numeric Rating Scale (NRS) items. The PEB Scale has 11 items rated 1-4, with a total score of 11-44; higher scores indicate stronger endorsement of the biopsychosocial model and represent a more favorable outcome. The Pain Beliefs Questionnaire has Organic Beliefs and Psychological Beliefs subscale mean scores ranging from 1-6; higher scores indicate stronger beliefs in the corresponding domain, with no uniformly better or worse direction. The University of Washington Pain-Related Self-Efficacy Scale Short Form has 6 items rated 1-5, with a total score of 6-30; higher scores indicate greater pain-related self-efficacy and represent a more favorable outcome. The three NRS items assess pain int |
At the initial assessment
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- PEB-TR-2026
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
No individual participant data will be shared with other researchers. The study involves sensitive health information, and participant confidentiality will be protected. Study findings will be reported in aggregate.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .